ALK-Abelló (Germany)

ALK-Abelló A/S, also commonly known as ALK, is a Denmark-based pharmaceutical company which specializes in the development and manufacturing of allergy immunotherapy products for the prevention and treatment of allergy. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for ALK-Abelló (Germany), Germany, covering academic research published from 2001 to 2023. Read More.

Open Access Percentage

59%

Total
Publications

Total Open
Publications

Total
Citations

3.2K

Open Access
Percentage

59%

Total
Publications

Total Open
Publications

Total
Citations

3.2K

Wikipedia

Website

download

Breakdown

Publisher Open

27%

Both

17%

Other Platform Open

15%

Closed

41%

Percentage of Open Access over time

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

Open

Closed

Publisher Open

OA Journal 30%

Hybrid 20%

No Guarantees 50%

Other Platform Open

Domain 52%

Institution 28%

Other Internet 24%

Preprint 14%

Public 3%

Other Platform Locations

Name	Platform Type	Publications
PubMed Central	Domain	15
Europe PMC	Domain	6
DOI	Other Internet	6
Unknown Repository	Other Internet	4
King's College London - Research Portal	Institution	2
bioRxiv	Preprint	2
Utrecht University - Utrecht University Repository	Institution	1
Universitätsbibliothek der Freien Universität Berlin - Refubium	Institution	1
University of Turin - Institutional Research Information System University of Turin	Institution	1
University of the Basque Country - Communities in ADDI	Institution	1

1 / 2

Data updated 8 December 2024